4.4 Article

Intra- and interindividual attack frequency variability of chronic cluster headache

Journal

CEPHALALGIA
Volume 43, Issue 2, Pages -

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/03331024221139239

Keywords

Cluster headache; clinical trials; headache

Ask authors/readers for more resources

This study analyzed the 12-week baseline data of the ICON trial and found that weekly and instantaneous recording of attack frequency are similar. The frequency of attacks is highest in spring, and patients with 3 or more daily attacks have less variability in attack frequency. The study suggests that weekly retrospective recording is as good as instantaneous recording and more convenient.
BackgroundThe lack of knowledge about the intra- and interindividual attack frequency variability in chronic cluster headache complicates power and sample size calculations for baseline periods of trials, and consensus on their most optimal duration. MethodsWe analyzed the 12-week baseline of the ICON trial (occipital nerve stimulation in medically intractable chronic cluster headache) for: (i) weekly vs. instantaneous recording of attack frequency; (ii) intra-individual and seasonal variability of attack frequency; and (iii) the smallest number of weeks to obtain a reliable estimate of baseline attack frequency. ResultsWeekly median (14.4 [8.2-24.0]) and instantaneous (14.2 [8.0-24.5]) attack frequency recordings were similar (p = 0.20; Bland-Altman plot). Median weekly attack frequency was 15.3 (range 4.2-140) and highest during spring (p = 0.001) compared to the other seasons. Relative attack frequency variability decreased with increasing attack frequency (p = 0.010). We tabulated the weekly attack frequency estimation accuracies compared to, and the associated deviations from, the 12-week gold standard for different lengths of the observation period. ConclusionWeekly retrospective attack frequency recording is as good as instantaneous recording and more convenient. Attack frequency is highest in spring. Participants with >= 3 daily attacks show less attack frequency variability than those with <3 daily attacks. An optimal balance between 90% accuracy and feasibility is achieved at a baseline period of seven weeks.The ICON trial is registered in ClinicalTrials.gov under number NCT01151631.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available